OUTCOMES

CureApp aims to create evidence-based innovations in the field of medicine
through actively incorporating evolving technologies.

2020

A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker

Author
Masaki K, Tateno H, Nomura A, Muto T, Suzuki S, Satake K, Hida E, Fukunaga K.
Journal
npj Digital Medicine.2020 March 12;3(1):1-7.

2019

Comparing Telemedicine and Face-to-Face Consultation Based on the Standard Smoking Cessation Program for Nicotine Dependence: Protocol for a Randomized Controlled Trial.

Author
Tanigawa T, Nomura A, Kuroda M, Muto T, Hida E, Satake K.
Journal
JMIR Res Protoc. 2019 Jul 9;8(7):e12701.

Cost-Effectiveness Analysis of Digital Therapy for the Patients with Nicotine Dependence

Author
Muto T, Tanigawa T, Nomura A, Ogawa T, Ikeda S, Satake K.
Journal
Japanese Journal of Telemedicine and Telecare, Vol.15 (1), 2019

Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial.

Author
Nomura A, Tanigawa T, Muto T, Oga T, Fukushima Y, Kiyosue A, Miyazaki M, Hida E, Satake K.
Journal
J Med Internet Res. 2019 Apr 26;21(4):e13520.

Impact of a Novel Smartphone App (CureApp Smoking Cessation) on Nicotine Dependence: Prospective Single-Arm Interventional Pilot Study.

Author
Masaki K, Tateno H, Kameyama N, Morino E, Watanabe R, Sekine K, Ono T, Satake K, Suzuki S, Nomura A, Betsuyaku T, Fukunaga K.
Journal
JMIR Mhealth Uhealth. 2019 Feb 19;7(2):e12694.

A Novel Smoking Cessation Smartphone App Integrated With a Mobile Carbon Monoxide Checker for Smoking Cessation Treatment: Protocol for a Randomized Controlled Trial.

Author
Nomura A, Tateno H, Masaki K, Muto T, Suzuki S, Satake K, Hida E, Fukunaga K.
Journal
JMIR Res Protoc. 2019 Feb 11;8(2):e12252.